Orforglipron: Once-daily pill (expected in 2026) Orforglipron is a new type of GLP-1 medicine which is taken as a once-daily pill instead of an injection
The more weight a participant shed, the greater the improvement in their body composition
While it identifies your genetic predisposition to weight loss response, it does not predict individual side effects like fever, but it does help your provider fine-tune your specific treatment plan for better outcomes and tolerability
The Staged Iftar Approach: Preventing Severe Nausea This is non-negotiable for GLP-1 patients
Darsalia V, Mansouri S, Ortsater H, Olverling A, Nozadze N, Kappe C, et al
The body burns more calories at rest when this pathway remains activated